South Korea's government is revving up regional exports of medical equipment, boosting the competitive pressures for device companies in Asia.
Covidien has made its first R&D foray into South Korea, opening a center to develop new technology, train local physicians and expand its share of a growing market.
GE Healthcare has signed up to buy mammography technology from South Korean X-ray outfit Vatech, expanding the company's imaging might and giving it a broader base in the growing local market.
While Thermo Fisher is busy raising cash to seal its $13.6 billion fate, Life Technologies is expanding its heft in South Korea, buying up another distributor in the growing market.
Problems at a Janssen over-the-counter plant in Korea have gone from unfortunate to very serious now that authorities there intend to pursue criminal charges. This tack means Kim Oak-yeon, CEO of the Johnson & Johnson ($JNJ) subsidiary in South Korea, faces up to three years in jail if convicted.
Life Technologies is fielding buyout offers from a competitor and a group of private equity giants, but that hasn't stopped the company from making acquisitions of its own, now snatching up a Korean distributor of reagents and lab instruments.
In what has been termed the worst pharmaceutical kickback scandal in years, 7 former and current executives of Korea's largest drugmaker, Dong-A Pharmaceutical, have been indicted for paying 4.8 billion won ($4.4 million) in kickbacks
Last week, Teva CEO Jeremy Levin promised that his company would conquer new markets around the globe. Now, Teva says it's taking its first step toward expanding in Asia.
Personalized medicine takes another step forward, as scientists from Pfizer and South Korea make progress developing a diagnostic test that can quickly and cheaply identify patients who can benefit from the company's lung cancer drug Xalkori (crizotinib).
Sigma-Aldrich is tapping the South Korean market with a deal to provide development support for active pharmaceutical ingredients for new non-steroidal anti-inflammatory drugs from a South Korean company.